New World Medical, Inc.

New World Medical, Inc. is a specialized surgical device manufacturer focused on glaucoma treatment solutions. Founded over 35 years ago, the company develops and distributes innovative implantable and minimally invasive devices for intraocular pressure management and vision preservation. The product portfolio includes the Ahmed® Glaucoma Valve, a proprietary valved drainage device; STREAMLINE® Surgical System, an implant-free solution utilizing ClickPulse® technology; Ahmed ClearPath®, a non-valved drainage option; KDB GLIDE®, a goniotomy surgical instrument; VIA360™ Surgical System for viscoelastic delivery; and human allograft tissue for glaucoma procedures. Products are marketed to ophthalmologists and ophthalmic surgical centers globally. The company operates in over 78 countries and emphasizes patient access over profit maximization, particularly in underserved markets. New World Medical maintains strong research and development capabilities and partnerships with surgeons and distributors worldwide. The organization dedicates 10% of annual profits to the Sidra Tree Foundation to democratize global eye care access. While specific FDA or regulatory certifications are not detailed in the provided content, the company's 35-year track record and international distribution suggest established regulatory compliance.